Scomnet in the spotlight after news of FDA approval

This combination of images provided by Edwards Lifesciences shows the Sapien 3 heart valve expanded, left, and crimped for insertion. AP filepic

PETALING JAYA: Shares of medical cable company Supercomnet Technologies Bhd (Scomnet) have been seeing some interest following news that its largest client, California-based Edwards Lifesciences Corp, has received approval for its heart valve systems from the US Food and Drug Administration (FDA) on Aug 16.

Edwards Lifesciences’ share price hit a record high of US$223.95 on Aug 19.